Summary
A collection of news and information related to Schering Plough Corporation published by Tribune Company sources.
» Search within 41 items
1
2
3
4
5
>
41 items on Schering Plough Corporation
1
2
3
4
5
>
-
Pfizer, Wyeth Benefit From Overseas Growth
Profits posted Wednesday by Pfizer Inc. and Wyeth show a common theme among pharmaceutical companies — nearly all the growth they're seeing these days is overseas, driven by emerging markets and the weak dollar. U.K.-based GlaxoSmithKline PLC,...Tags: Pharmaceuticals, Emerging Market, Pfizer Incorporated, Merck & Company Incorporated, GlaxoSmithKline
-
New Jersey: Cholesterol pill fails to lower risks
In the latest disappointment for the cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn't prevent worsening of the disease or lower the need for valve surgery. Results of a preliminary analysis of...Tags: New Jersey, Diseases, Heart Disease, Merck & Company Incorporated, Death and Dying
-
Cholesterol drug faulted in study
TRENTON, N.J. In the latest disappointment for the cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn't prevent worsening of the disease or lower the need for valve surgery. Results of a preliminary...Tags: Medicine, Merck & Company Incorporated, Western Medicines
-
|Story
Tags: Merck & Company Incorporated
-
Cholesterol pill Vytorin fails heart-valve test in Europe
In the latest disappointment for cholesterol pill Vytorin, a major European study in patients with heart-valve disease found the drug didn't prevent worsening of the disease or lower the need for valve surgery, sending its makers' stock plunging. Results...Tags: Diseases, University of Wisconsin-Madison, Heart Disease, Waste, Animal Science
-
Vytorin study sends makers' stock plunging
Tribune wire reportsTRENTON, N.J. _ A major European study in patients with heart valve disease found the drug Vytorin didn't prevent worsening of the disease or lower the need for surgery, sending its makers' stock plunging. Results of a preliminary analysis of the just-...Tags: Cleveland Clinic, Parliament, Cancer, Western Medicines, Sales
-
Vytorin Misses Study Goal
In the latest disappointment for cholesterol pill Vytorin, a major European study in patients with heart valve disease found that the drug did not prevent worsening of the disease or lower the need for valve surgery, sending its makers' stock plunging....Tags: Diseases, Heart Disease, Kenilworth, Merck & Company Incorporated, Death and Dying
-
Oil, profit-taking nudge stocks down
Wall Street lost ground, with investors pulling back from last week's big rally as they watched the price of oil advance. The tame session unfolded as oil rose on concerns that the threat of new sanctions against Iran over its nuclear program could...Tags: Economic Sanctions, Stocks, Foreign Aid, Merck & Company Incorporated, Metal and Mineral
-
How to use sunscreen wisely
Chicago TribuneSunscreen is commonly hailed as safe, essential body armor. It protects us from blistering sunburn, keeps our skin from wrinkling and helps guard against squamous cell cancer. But the evidence is inconclusive as to whether sunscreens reduce the risk of...Tags: Diseases, Health Organizations, Medical Specialization, Cancer, California
-
NJ to lose more than 800 pharmaceutical jobs
More than 800 pharmaceutical jobs will be leaving New Jersey starting in August. Most of the job cuts and transfers are part of major previously announced restructurings at Johnson & Johnson and Schering-Plough Corp. This week, the companies specified...Tags: New Jersey, Centocor Incorporated, Kenilworth, Abbott Laboratories
Jul 24, 2008
|Story| Hartford Courant
Jul 22, 2008
|Story| South Florida Sun-Sentinel
Jul 22, 2008
|Story| Baltimore Sun
Jul 21, 2008
|Story| Hola Hoy
Jul 22, 2008
|Story| Orlando Sentinel
Jul 21, 2008
|Story| Chicago Tribune
Jul 22, 2008
|Story| Hartford Courant
Jul 22, 2008
|Story| Chicago Tribune
Jul 15, 2008
|Story| South Florida Sun-Sentinel
Jul 8, 2008
|Story| Associated Press
